Protea Fund - Sectoral Biotech Opportunities Fund Class IF Fonds
9,73
EUR
+0,01
EUR
+0,10
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Amgen Inc | US0311621009 | 7,76% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 7,74% |
| Gilead Sciences Inc | US3755581036 | 7,69% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,27% |
| AstraZeneca PLC ADR | US0463531089 | 4,79% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,50% |
| argenx SE ADR | US04016X1019 | 4,50% |
| Insmed Inc | US4576693075 | 3,67% |
| BeOne Medicines Ltd ADR | US07725L1026 | 3,08% |
| Summit Therapeutics Inc Ordinary Shares | US86627T1088 | 3,02% |
| Sonstige | 47,99% |